Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity
- 10 April 2007
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 80 (18) , 1641-1649
- https://doi.org/10.1016/j.lfs.2006.12.041
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Lysophosphatidic Acid Binds to and Activates GPR92, a G Protein-Coupled Receptor Highly Expressed in Gastrointestinal LymphocytesThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasmaFEBS Letters, 2004
- Biology of LPA in health and diseaseSeminars in Cell & Developmental Biology, 2004
- Lysophosphatidic acid production and action: Validated targets in cancer?Journal of Cellular Biochemistry, 2004
- Lysophospholipid Receptors: Signaling and BiologyAnnual Review of Biochemistry, 2004
- Lysophosphatidic Acid (LPA) in Malignant Ascites Stimulates Motility of Human Pancreatic Cancer Cells through LPA1Journal of Biological Chemistry, 2004
- Role of phospholipase D in agonist-stimulated lysophosphatidic acid synthesis by ovarian cancer cellsJournal of Lipid Research, 2003
- The emerging role of lysophosphatidic acid in cancerNature Reviews Cancer, 2003
- Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg FamilyJournal of Biological Chemistry, 2003
- Phorbol 12-Myristate 13-Acetate Stimulates Lysophosphatidic Acid Secretion from Ovarian and Cervical Cancer Cells but Not from Breast or Leukemia CellsGynecologic Oncology, 1998